BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10582590)

  • 1. Sublytic terminal complement complexes decrease P0 Gene expression in Schwann cells.
    Dashiell SM; Koski CL
    J Neurochem; 1999 Dec; 73(6):2321-30. PubMed ID: 10582590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JNK1 activation mediates C5b-9-induced P0 mRNA instability and P0 gene expression in Schwann cells.
    David S; Hila S; Fosbrink M; Rus H; Koski CL
    J Peripher Nerv Syst; 2006 Mar; 11(1):77-87. PubMed ID: 16519786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminal complement complexes concomitantly stimulate proliferation and rescue of Schwann cells from apoptosis.
    Dashiell SM; Rus H; Koski CL
    Glia; 2000 Apr; 30(2):187-98. PubMed ID: 10719360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublytic C5b-9-stimulated Schwann cell survival through PI 3-kinase-mediated phosphorylation of BAD.
    Hila S; Soane L; Koski CL
    Glia; 2001 Oct; 36(1):58-67. PubMed ID: 11571784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tellurium causes dose-dependent coordinate down-regulation of myelin gene expression.
    Toews AD; Roe EB; Goodrum JF; Bouldin TW; Weaver J; Goines ND; Morell P
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):113-9. PubMed ID: 9387870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublytic terminal complement attack on myotubes decreases the expression of mRNAs encoding muscle-specific proteins.
    Lang TJ; Badea TC; Wade R; Shin ML
    J Neurochem; 1997 Apr; 68(4):1581-9. PubMed ID: 9084429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublytic complement attack induces cell cycle in oligodendrocytes.
    Rus HG; Niculescu F; Shin ML
    J Immunol; 1996 Jun; 156(12):4892-900. PubMed ID: 8648139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes.
    Shirazi Y; Rus HG; Macklin WB; Shin ML
    J Immunol; 1993 May; 150(10):4581-90. PubMed ID: 7683324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early activation of transcription factor expression in Schwann cells by progesterone.
    Mercier G; Turque N; Schumacher M
    Brain Res Mol Brain Res; 2001 Dec; 97(2):137-48. PubMed ID: 11750070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells.
    Désarnaud F; Do Thi AN; Brown AM; Lemke G; Suter U; Baulieu EE; Schumacher M
    J Neurochem; 1998 Oct; 71(4):1765-8. PubMed ID: 9751213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased P0 glycoprotein gene expression in primary and transfected rat Schwann cells after treatment with axolemma-enriched fraction.
    Knight RM; Fossom LH; Neuberger TJ; Attema BL; Tennekoon G; Bharucha V; DeVries GH
    J Neurosci Res; 1993 May; 35(1):38-45. PubMed ID: 7685396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice.
    Patzkó A; Bai Y; Saporta MA; Katona I; Wu X; Vizzuso D; Feltri ML; Wang S; Dillon LM; Kamholz J; Kirschner D; Sarkar FH; Wrabetz L; Shy ME
    Brain; 2012 Dec; 135(Pt 12):3551-66. PubMed ID: 23250879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal Id expression and myelin gene regulation in Schwann cells.
    Thatikunta P; Qin W; Christy BA; Tennekoon GI; Rutkowski JL
    Mol Cell Neurosci; 1999 Dec; 14(6):519-28. PubMed ID: 10656257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein zero is necessary for E-cadherin-mediated adherens junction formation in Schwann cells.
    Menichella DM; Arroyo EJ; Awatramani R; Xu T; Baron P; Vallat JM; Balsamo J; Lilien J; Scarlato G; Kamholz J; Scherer SS; Shy ME
    Mol Cell Neurosci; 2001 Dec; 18(6):606-18. PubMed ID: 11749037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Schwann cell phenotype by TGF-beta 1: inhibition of P0 mRNA expression and downregulation of the low affinity NGF receptor.
    Mews M; Meyer M
    Glia; 1993 Jul; 8(3):208-17. PubMed ID: 7693590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel P0 glycoprotein transgene activates expression of lacZ in myelin-forming Schwann cells.
    Feltri ML; D'antonio M; Quattrini A; Numerato R; Arona M; Previtali S; Chiu SY; Messing A; Wrabetz L
    Eur J Neurosci; 1999 May; 11(5):1577-86. PubMed ID: 10215910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of myelin P0 glycoprotein synthesis in cultured rat Schwann cells and continuous rat PNS cell lines.
    Kreider B; Zeller N; Lazzarini R; Shuman S; Pleasure D
    J Neurochem; 1988 Aug; 51(2):566-71. PubMed ID: 2455775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Po gene expression is modulated by androgens in the sciatic nerve of adult male rats.
    Magnaghi V; Cavarretta I; Zucchi I; Susani L; Rupprecht R; Hermann B; Martini L; Melcangi RC
    Brain Res Mol Brain Res; 1999 Jun; 70(1):36-44. PubMed ID: 10381541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P0 mRNA expression in cultures of Schwann cells and neurons that lack basal lamina and myelin.
    Brunden KR; Brown DT
    J Neurosci Res; 1990 Oct; 27(2):159-68. PubMed ID: 1701492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of changes in P0 mRNA by polymerase chain reaction in primary cultured Schwann cells stimulated by axolemma-enriched fraction.
    Clive DR; Lopez TJ; DeVries GH
    J Neurosci Methods; 1998 Jun; 81(1-2):25-34. PubMed ID: 9696306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.